Skip to main content
logo
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.3180
0.00 (0.00%)
Last updated: Jul 28, 2026, 8:02 AM CET

Biomark Diagnostics Financials Overview

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
0.090.150.160.150.04-
Revenue Growth
-40.80%-5.52%6.34%249.38%--
Gross Profit
0.090.150.160.150.04-
Operating Income
-1.97-2.05-1.71-1.84-1.28-1.03
Net Income
-1.7-1.93-1.43-1.84-1.45-1.09
Earnings Per Share
-0.02-0.02-0.02-0.02-0.02-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
1.292.480.160.070.380.88
Total Debt
0.711.121.551.651.971
Net Cash (Debt)
0.571.36-1.39-1.58-1.58-0.13
Net Cash Growth
------
Net Cash Per Share
0.010.01-0.02-0.02-0.02-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
-1.42-1.09-0.98-0.91-1.2-0.81
Capital Expenditures
-0.63-0-0-0.01-0.06-
Free Cash Flow
-2.05-1.1-0.99-0.92-1.26-0.81
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-2145.47%-1327.45%-1046.96%-1198.95%-2922.50%-
Pretax Margin
-1852.06%-1249.73%-874.52%-1200.21%-3309.36%-
Profit Margin
-1852.06%-1249.73%-874.52%-1200.21%-3309.36%-
FCF Margin
-2234.05%-711.12%-604.65%-599.20%-2875.13%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
PS Ratio
594.01145.04152.12100.50356.91-